Abstract
Visceral leishmaniasis is a neglected disease that mainly affects developing countries. Available chemotherapy for the treatment of leishmaniasis has a reduced number of drugs, with severe adverse effects and progressive increase of resistance. Drug repositioning consists in the search for new uses for approved drugs and is a great opportunity to introduce new therapies by significantly r…